|
(866) 998-8855
 |
 |
|
|
 |
Home > Amino Acids > Acetyl-L-Carnitine >
| Acetyl-L-Carnitine (ALC) is a naturally occurring form
of L-Carnitine, a vitamin-like nutrient synthesized in the body from the
amino acids lysine and methionine. ALC serves as a transport molecule
for "active acetate," which is a source of fuel for metabolic processes
that take place in cells. ALC carries active acetate (the "Acetyl"
portion) directly into the mitochondrion, the cell's energy-generating
structure. Active acetate is used to produce cellular energy in the form
of ATP. Both L-Carnitine and ALC serve as fat carriers. Unlike L-Carnitine,
ALC readily crosses the blood-brain barrier, where it has specific
benefits for brain neurons. When taken orally, ALC has been shown to
increase ALC levels in both blood and cerebrospinal fluid, demonstrating
its uptake in the brain.1
Best Acetyl-L-Carnitine consists of Biosintâ„¢ Acetyl-L-Carnitine,
which is manufactured in Italy by the Sigma Tau company. It is derived
from a base of pharmaceutical-grade L-Carnitine manufactured using an
FDA-approved process that fully complies with international monograph
standards for carnitine production. Known as a global leader in
L-Carnitine research, Sigma Tau holds numerous patents for production of
L-Carnitine, and its L-Carnitine derivatives, such as ALC, which are
used in clinical trials.
|
|
Supports cognitive function*
ALC has been studied for its effect on cognitive performance and
emotional health in the elderly. In a single-blind, placebo-controlled
trial, 481 elderly subjects exhibiting mild memory impairment improved
their scores on a memory test after taking 1500 mg of ALC a day for 90
days.2 Hospitalized elderly people taking ALC have
shown improvements in mental outlook.3
While ALC is not a treatment or cure for Alzheimer's disease,
double-blind studies suggest it may help slow the rate at which
early-stage Alzheimer's patients deteriorate.4 In
particular, ALC seems to benefit short-term memory in these patients.5
Supports biosynthesis of acetylcholine, a key neurotransmitter for
brain and nerve function*
Brain function requires coordinated communication between brain
cells. Brain and nerve cells ("neurons") communicate across tiny
cell-to-cell gaps called "synapses." The passage of an electrical
impulse from one neuron to the next requires a "neurotransmitter." When
an electrical signal arrives at the synaptic junction, the neuron
releases a neurotransmitter into the synapse. The neuron on the other
side of the synapse contains receptors for the neurotransmitter; these
receptors bind the neurotransmitter, triggering a series of chemical
events that sends a new electrical signal down the membrane of the
receiving neuron. Neurotransmitters work together like an orchestra to
transmit information throughout the brain and nervous system.
Acetylcholine is the most abundant neurotransmitter in the body,
regulating activities of vital organs, blood vessels and communication
between nerves and muscles. In the brain, acetylcholine helps facilitate
memory and learning as well as influence emotions. ALC is structurally
similar to acetylcholine, and brain neurons stimulated by acetylcholine
are receptive to stimulation by ALC.6 It has been
shown experimentally that ALC supplies acetyl groups for the
biosynthesis of acetylcholine.7 ALC's hypothesized
cholinomimetic (acts like acetylcholine) activity has led researchers to
investigate its effects on mental function and emotional health.8
Helps supply the brain with energy by improving energetics in the
mitochondrion*
The acetyl groups donated by ALC can be used to synthesize
acetyl-CoA, the key substrate for energy metabolism in the
mitochondrion. 9 Acetyl-CoA enters the Krebs
cycle, the mitochondrial mechanism that generates cellular energy in the
form of ATP. ALC easily crosses the blood-brain barrier, allowing it to
play various roles in maintaining brain neuron (nerve cell) function.
When given by oral administration, the concentration of ALC is increased
in the blood and cerebrospinal fluid.10
Stabilizes intracellular membranes*
ALC was found to improve membrane phospholipid metabolism in
early-stage Alzheimer's patients.11 Phospholipids
are structural components of brain cell membranes that regulate neuron
function. ALC donates acetyl groups that can be used to modify the
functional activity of proteins in neuronal membranes.12
ALC thus plays a role in maintaining membrane function. ALC also
increases membrane stability and structural integrity.13
Increases nerve growth factor production*
The body produces various specialized proteins called "growth
factors" which are essential to growth and repair of tissue. Nerve
Growth Factor (NGF) protects neurons from death, prolonging survival of
neurons in both the central and peripheral nervous systems. It is
theorized that aging of the central nervous system is associated with a
loss of NGF. ALC has shown the ability to reverse age-related decrease
in the binding of NGF to its receptors in neuron membranes.14 Given to aged rats, ALC increases the level and utilization of
NGF in the rats. ALC protects cholinergic neurons (nerve cells
stimulated by acetylcholine) in rats from degeneration due to lack of
NGF.15 These results, together with other data
from animal studies, suggest that ALC positively influences NGF
activity.16
Has a protective influence on brain neurons*
Several animal studies have revealed that ALC exerts a protective
effect on neurons. In one experiment, brain cells from rats exposed to
NMDA, a known neurotoxin, were protected by being simultaneously exposed
to ALC.17 Rats injected with ALC were protected
from mortality caused by the neurotoxin MPP+.18
ALC has been shown to raise levels of glutathione, a highly valuable
antioxidant, in isolated mouse brain tissue.19 ALC
prevents buildup of malondyhaldeyde, a marker of lipid peroxidation.20
ALC is also a chelator of iron, which can generate free radicals. It
also reinforces antioxidant mechanisms in the brain.21
As a whole, data from test tube and animal studies, showing that ALC
has a protective, restorative effect on brain neurons and neuronal
energetic processes, suggest that ALC is an anti-aging nutrient for the
brain. This hypothesis is supported by human studies demonstrating
measurable benefits for brain function in elderly persons taking ALC by
oral consumption.
|
Suggested Adult Use: 1 to 4 capsules daily.
ALC is considered safe and well-tolerated when consumed orally.
ALC has been administered in doses as high as 3 grams per day for
periods of two to six months, with no reports of serious side effects.
Some patients have experienced occasional mild abdominal discomfort,
nausea, skin rash, restlessness, vertigo and headache. The severity and
incidence of these side effects are reported as minor.22
|
1. Pettegrew, JW, Levine, J, McClure, RJ. Acetyl-L-carnitine
physical-chemical, metabolic, and therapeutic properties: relevance for
its mode of action in Alzheimer's disease and geriatric depression.
Molecular Psychiatry 2000;5:616-32.
2. Salvioli, G. Neri , M. L-acetylcarnitine treatment of mental decline
in the elderly. Drugs Exptl. Clin. Res. 1994; 20(4):169-76.
3. Tempesta, E, et al. L-acetylcarnitine in depressed elderly subjects.
A cross-over study vs. placebo. Drugs Exptl. Clin. Res.
1987;8(7):417-23.
4. Spagnoli, A et al. Long-term acetyl-L-carnitine treatment in
Alzheimer's disease. Neurology 1991;41:1726-32.
5. Rai, G et al. Double-blind, placebo-controlled study of acetyl-L-carnitine
in patients with Alzheimer's dementia. Curr. Med Res. Opin.
1990;11:638-47.
6. Falchetto, S, Kato, G, Provini, L. The action of carnitines on
cortical neurons. Can J Physiol Pharmacol 1971; 49(1):1:7.
7. Dolezal, V., Tucek, S. Utilization of citrate, acetylcarnitine,
acetate, pyruvate and glucose for the synthesis of acetylcholine in rat
brain slices. J Neurochem 1981;36(4):1323.30.
8. Passeri, M, et al. Mental impairment in aging: selection of patients,
methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
Int. J. Clin. Pharm. Res. 1988;8(5):367-76.
9. Pettegrew, JW, Levine, J, McClure, RJ. Acetyl-L-carnitine
physical-chemical, metabolic, and therapeutic properties: relevance for
its mode of action in Alzheimer's disease and geriatric depression.
Molecular Psychiatry 2000;5:616-32.
10. Parnetti, L, et al. Pharmacokinetics of IV and oral acetyl-L-carnitine
in multiple dose regimen in patients with senile dementia of Alzheimer
type. Eur. J. Clin Pharmacol 1992;42:89-93.
11. Pettegrew, JW, et al. Clinical and neurochemical effects of
acetyl-L-carnitine in Alzheimer's disease. Neurobiology of Aging
1995;16(1):1-4.
12. Pettegrew, JW, Levine, J, McClure, RJ. Acetyl-L-carnitine
physical-chemical, metabolic, and therapeutic properties: relevance for
its mode of action in Alzheimer's disease and geriatric depression.
Molecular Psychiatry 2000;5:616-32.
13. Arduni, A, et al. Effect of L-carnitine and acetyl-L-carnitine on
the human erythrocyte membrane stability and deformability. Life Sci
1990;47(26):2395-2400.
14. Taglialatela, G, et al. Stimulation of nerve growth factor receptors
in PC12 by acetyl-L-carnitine. Biochem Pharmacol 1992;44(3):577-85.
15. Taglialatela, G, et al. Acetyl-L-carnitine treatment increases nerve
growth factor levels and choline acetyltransferase activity in the
central nervous system of aged rats. Exp Gerontol 1994;29(1):55-56.
16. Pettegrew, JW, Levine, J, McClure, RJ. Acetyl-L-carnitine
physical-chemical, metabolic, and therapeutic properties: relevance for
its mode of action in Alzheimer's disease and geriatric depression.
Molecular Psychiatry 2000;5:616-32.
17. Forloni, G, Angeretti, N, Smiroldo, S. Neuroprotective activity of
acetyl-L-carnitine: studies in vitro. J Neurosci Res 1994;37(1):92-6.
18. Steffen, V, et al. Effect of intraventricular injection of
1-methyl-4-phenylpyridinium: protection by acetyl-L-carnitine. Hum Exp
Toxicol 1995;14(11):865-71.
19. Fariello, RG, et al. Systemic acetyl-L-carnitine elevates nigral
levels of glutathione and GABA. Life Sci 1988;43(3):289-92.
20. Calvani, M, et al. Action of acetyl-L-carnitine in neurodegeneration
and Alzheimer's disease. Ann Ny Acad Sci 1992;663:483-86.
21. Calvani, M, Carta, A. Clues to the mechanism of action of
acetyl-L-carnitine in the central nervous system. Dementia 1991;2:1-6.
22. Zdanowicz, M. Acetyl-L-carnitine's healing potential. Continuing
Education Module. New Hope Institute of Retailing. October, 2001.
|
|